Eisai
4523.T
24,41 €
Share price
0.95%
Change (1 day)
-33.69%
Change (1 year)
Categories
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.
EPS for Eisai (4523.T)
EPS in 2023 (TTM): 2,05 €
According to Eisai's latest financial reports the company's current EPS (TTM) is 1,99 €. In 2022 the company made an earnings per share (EPS) of 1,46 € a decrease over its 2021 EPS that were of 6,49 €.
EPS history for Eisai from 2009 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | 2,05 € | 40.37% |
| 2022 | 1,46 € | -77.48% |
| 2021 | 6,49 € | -41.88% |
| 2020 | 11,17 € | -0.94% |
| 2019 | 11,27 € | 52.59% |
| 2018 | 7,39 € | 124.17% |
| 2017 | 3,30 € | -49.42% |
| 2016 | 6,52 € | 37.08% |
| 2015 | 4,75 € | -11.75% |
| 2014 | 5,39 € | -3.23% |
| 2013 | 5,57 € | -18.56% |
| 2012 | 6,83 € | -15.51% |
| 2011 | 8,09 € | -3.75% |
| 2010 | 8,41 € | -1.36% |
| 2009 | 8,52 € |